Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Cash from Financing Activities (2022 - 2025)

Historic Cash from Financing Activities for ASP Isotopes (ASPI) over the last 4 years, with Q3 2025 value amounting to $56.7 million.

  • ASP Isotopes' Cash from Financing Activities rose 7487.13% to $56.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $125.2 million, marking a year-over-year increase of 6977.08%. This contributed to the annual value of $82.5 million for FY2024, which is 51659.03% up from last year.
  • According to the latest figures from Q3 2025, ASP Isotopes' Cash from Financing Activities is $56.7 million, which was up 7487.13% from $51.0 million recorded in Q2 2025.
  • In the past 5 years, ASP Isotopes' Cash from Financing Activities registered a high of $56.7 million during Q3 2025, and its lowest value of -$225096.0 during Q1 2025.
  • Over the past 4 years, ASP Isotopes' median Cash from Financing Activities value was $10.5 million (recorded in 2023), while the average stood at $17.5 million.
  • In the last 5 years, ASP Isotopes' Cash from Financing Activities skyrocketed by 35095.14% in 2024 and then plummeted by 10111.08% in 2025.
  • ASP Isotopes' Cash from Financing Activities (Quarter) stood at $3.8 million in 2022, then surged by 134.56% to $8.9 million in 2023, then soared by 98.97% to $17.7 million in 2024, then surged by 220.5% to $56.7 million in 2025.
  • Its last three reported values are $56.7 million in Q3 2025, $51.0 million for Q2 2025, and -$225096.0 during Q1 2025.